Purchase Order 75N91024P00281
Award Date 3/15/24
Potential Completion Date 9/15/24
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order contract valued at $25,000 by the National Cancer Institute within the National Institutes of Health, part of the Department of Health and Human Services. The contract is for laboratory testing services to support the research efforts of the National Cancer Institute. Per the award notice, Engene will provide testing services with no subcontractors involved and no set aside...
- Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Institutes of Health's National Cancer Institute to provide testing services in support of biomedical research projects involving high throughput data analysis. With a potential value of $19,123, this purchase order has a completion date of March 14, 2024 and was awarded on November 1, 2023. No major subcontractors or set aside designations were specified. Engene...
- This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, to Engene Statistics GMBH, doing business as Engene Statistics Sagl, a for-profit organization based in Switzerland. The $23,530.37 contract is for laboratory testing services to support biomedical research projects involving high throughput data analysis, particularly in the field of cancer...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order for $1 million to $5 million to Engene Statistics Sagl of Switzerland for laboratory testing services. Under this contract, Engene Statistics will provide testing support to advance the National Cancer Institute's biomedical research mission. As a small business located in Switzerland, Engene Statistics will leverage their scientific expertise to help...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,407 purchase order to Engene Statistics Sagl of Switzerland for testing services. Under the firm fixed price contract, Engene Statistics Sagl will provide unspecified testing services to the National Cancer Institute from July 31, 2023 through October 31, 2023. The contract was awarded directly to Engene Statistics Sagl as the prime contractor, with no mention of major...
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $86,760 firm fixed price delivery order contract to Steinbeis GMBH & CO. KG FÜR Technologietransfer of Almanya for assay services. As the prime contractor, Steinbeis will provide testing and analysis for the National Institute of Environmental Health Sciences through October 2, 2024. The contract was awarded on April 3, 2023 without a set-aside...
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Genus Biosystems Inc., a for-profit organization, for $23,520.00 to provide lab testing services. The contract has a completion date of November 1, 2024 and was awarded on May 1, 2024. The place of performance is Northbrook, IL 60062, USA. This contract award is not associated with any set-aside designation.</p>
- <p>The National Cancer Institute issued a delivery order to Genepria Consulting Inc. on August 16, 2018, with a ceiling value of $17,250.00 under firm fixed price terms.</p> <p>Place of performance is Bethesda, Maryland. The order was scheduled for ultimate completion on September 16, 2019. No set-aside was used for this delivery order.</p>
- This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $27,400.00, is for lab testing services and was set aside for a small business, Enamine US Inc. Based in New Jersey, Enamine US Inc. is a for-profit organization that specializes in chemical research and pharmaceutical services, and has a history of delivering...
- Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order totaling $24,864 by the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health. The contract calls for Novogene to provide laboratory testing services in Bethesda, Maryland, in support of the agency's biomedical research efforts. As a previous provider of genomic sequencing and bioinformatics services under over 100 federal...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Cancer Institute within the National Institutes of Health, part of the Department of Health and Human Services. The $20,000 contract requires Engene to provide laboratory testing services in support of biomedical research projects involving high throughput data analysis. Performance will take place at the National Cancer Institute location in Bethesda, Maryland and be completed by September 15, 2024. No set aside designation or major subcontractors were specified for this laboratory testing contract.
Generated 3/8/24, 9:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 3/7/24 |